BEIGF News and Press, BeiGene

2026-02-26 16:07:50 ET BeOne Medicines AG (ONC) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Company Participants Daniel Maller - Vice President of Investor Relations John Oyler - Co-Founder, Executive Chairman & CEO Aaron Rosenberg - Chief Financial Off...

2026-01-13 12:55:57 ET BeOne Medicines AG (ONC) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 10:30 AM EST... Read the full article on Seeking Alpha For further details see: BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference T...

2025-12-16 09:19:08 ET This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers’ 13F stock portfolio on a quarterly basis. It is based on Baker Brothers’ regulatory 13F Form filed on 11/14/2025. The 13F portfolio value in...

2025-11-18 12:24:45 ET More on Zymeworks Jazz Pharmaceuticals' And Zymeworks' Ziihera Success: A Pleasant Surprise Zymeworks Surges On Positive Ziihera Phase 3 Data: Expanding First-Line GEA Opportunity Zymeworks Inc. (ZYME) Q3 2025 Earnings Call Transcript J...

2025-11-17 13:17:06 ET BeOne Medicines AG (ONC) Jefferies London Healthcare Conference 2025 November 17, 2025 11:00 AM EST... Read the full article on Seeking Alpha For further details see: BeOne Medicines AG (ONC) Presents at Jefferies London Healthcare Conference 2025 Tran...

2025-11-17 07:13:52 ET More on Jazz Pharmaceuticals, Zymeworks, etc. BeOne Medicines AG (ONC) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript Zymeworks Inc. (ZYME) Q3 2025 Earnings Call Transcript BeOne Medicines AG (ONC) Q3 2...

2025-11-16 09:16:14 ET More on Pinterest, Electronic Arts, etc. Meta Platforms: Reasonably Valued With One Key Caveat Meta's Capex Plans Could Lead To Their iPhone Moment Meta: Why The Recent Selloff Is A Buying Opportunity (Rating Upgrade) Government disclos...

2025-11-11 02:11:34 ET BeOne Medicines AG (ONC) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 9:30 AM EST... Read the full article on Seeking Alpha For further details see: BeOne Medicines AG (ONC) Presents at Guggenheim Securities 2nd A...

2025-11-06 15:17:04 ET More on BeiGene BeOne Medicines AG (ONC) Q3 2025 Earnings Call Transcript BeOne Medicines AG 2025 Q3 - Results - Earnings Call Presentation BeOne Medicines: Sonrotoclax Could Set Next Stage Of Growth For Hematology Pipeline BeiGene Non-...

2025-11-06 15:16:13 ET BeOne Medicines AG (ONC) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Daniel Maller John Oyler - Co-Founder, Executive Chairman & CEO Aaron Rosenberg - Chief Financial Officer Wang Lai - Global Head of Res...